Research output per year
Research output per year
Personal profile
Education/Academic qualification
Master, Master of Business Administration in Healthcare, University of Amsterdam
2016 → 2018
Award Date: 13 Apr 2018
PhD, Immunodiagnostics and immune surveillance in an era of evolving immunotherapeutic strategies in AML
2007 → 2011
Award Date: 29 Nov 2013
Master, Medicine, VU Medical School, Amsterdam
2001 → 2013
Award Date: 10 May 2013
External positions
Resident Clinical Chemistry, Department of Hematology and Clinical Chemistry Laboratories, OLVG, Oosterparkstraat 9, 1091 AC, Amsterdam
1 Nov 2013 → 31 Jul 2018
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Unfractionated heparin and the activated clotting time in non-cardiac arterial procedures
Roosendaal, L. C., van den Ancker, W., Wiersema, A. M., Blankensteijn, J. D. & Jongkind, V., 1 Oct 2023, In: Journal of Cardiovascular Surgery. 64, 5, p. 488-494 7 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Direct sodium measurement prevents underestimation of hyponatremia in critically ill patients
van den Ancker, W., Haagen, I. A. & van der Voort, P. H. J., Mar 2015, In: Intensive care medicine. 41, 3, p. 553-4 2 p.Research output: Contribution to journal › Article › Academic › peer-review
13 Citations (Scopus) -
Actieve immuuntherapie bij acute myeloïde leukemie
Ruben, J. M., van den Ancker, W., Westers, T. M., Ossenkoppele, G. J., de Gruijl, T. D. & van de Loosdrecht, A. A., 2014, In: Nederlands Tijdschrift voor Hematologie. 11, 3, p. 91-99Research output: Contribution to journal › Article › Professional
-
Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines
Ruben, J. M., van den Ancker, W., Bontkes, H. J., Westers, T. M., Hooijberg, E., Ossenkoppele, G. J., de Gruijl, T. D. & van de Loosdrecht, A. A., 2014, In: Cancer immunology and immunotherapy. 63, 4, p. 335-345Research output: Contribution to journal › Article › Academic › peer-review
29 Citations (Scopus) -
Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia
van Luijn, M. M., van den Ancker, W., van Ham, S. M. & van de Loosdrecht, A. A., Dec 2014, In: Oncoimmunology. 3, 12, p. e941737 e941737.Research output: Contribution to journal › Article › Academic › peer-review
3 Citations (Scopus)